Event recap

Insights from Asembia 2025

Our thought leadership in action

Explore some of our expert contributions, panel discussions and related content that showcased our commitment to create healthier futures. 

Session

The Business Imperative: Addressing Healthcare Inequities for Sustainable Growth and Strategies to Prioritize Business Growth and Innovation 

Healthcare inequities are more than just social issues—they are business challenges that directly impact profitability, market growth, and organizational sustainability. In this session, we bring together thought leaders and industry pioneers to explore how addressing healthcare disparities is not only ethically necessary but also a strategic business advantage. Discover how innovative solutions and collaborative strategies can enhance patient outcomes, expand market reach, and drive sustainable growth. 

View the speaking session slides here

Chara Reid
National GPO Sales Senior Director, Cencora 
Christie Smith
Vice President, Payer Strategy, Cencora
Melissa Paige
President, National Association of Medication Access & Patient Advocacy (NAMAPA)

Session

Challenges in IRA Maximum Fair Price Effectuation: Evaluating the Retrospective and Prospective MFP Models 

With Maximum Fair Price (MFP) going live in January of 2026, industry efforts to understand how to those prices will flow through the channel are underway with two potential methodologies deemed compliant by CMS. While the industry evaluates these models, concerns have arisen from both manufacturers and pharmacies. During this session, Cencora discusses perspectives from our customers both upstream and downstream, providing insights into the challenges that industry is currently working to solve.  

View the speaking session slides here

Tyler Novotny
Vice President, Market Economics, Cencora
Caleb Debenham
Senior Director, Global Products & Solutions, Cencora
Megan Law
Senior Director, Portfolio Account, Cencora
Whitley Quan
Manager, U.S. Public Policy, Government Affairs, Cencora

Catch up on our latest insights

gps_025_ic_content_WP_euro_market

Why an integrated approach ensures smooth entry into the European market

Global expansion from U.S. biotech companies is important for company growth and patient reach. Learn how Cencora helps pharma companies navigate an EU launch by managing complexities surrounding regulatory, licensing, distribution, and more.
htaq

HTA Quarterly Spring 2025

In this edition, following the implementation of the European Union (EU) Regulation on Health Technology Assessment (HTAR) for medicinal products in January, we review current processes and prepare for upcoming guidance for medical devices. We also discuss the value of early network mapping in systemic literature reviews (SLRs) for health technology assessment (HTA) submissions and spotlight the improved drug pricing environment in Japan, a result of positive changes to the pricing system adopted in April 2024.
clinical-development-oncology-therapy

Mastering the complexities of targeted medicines

Targeted medicines are redefining modern healthcare by providing personalized therapies meticulously designed to address each patient’s unique disease profile. Given the early success of targeted medicines, such therapies hold great promise, but this often brings new complexities to navigate. Embark on a journey to master the complexities of targeted medicines in this white paper from Cencora.
US Capitol building

Stay informed about US Health Policy News

Health Policy Weekly

US Capitol building

Health Policy weekly recaps legislative and regulatory developments and healthcare reform news that impacts the healthcare industry, particularly pharmaceutical, biotech, and device manufacturers, providers, and managed care.

Developed by a multi-disciplinary editorial board that includes health policy and reimbursement strategy experts, Health Policy Weekly delivers key insights to your inbox every week. 

US Capitol building
Xcenda_2_3_Card-02

Keep up on key global health technology assessment news

HTA Quarterly

Xcenda_2_3_Card-02
Each edition of HTA Quarterly provides insights and analysis from global experts with local market expertise on key priorities and perspectives affecting HTA.
From therapeutic area spotlights to geographic reviews to critical industry topics, keep current on HTA activity around the globe with HTA Quarterly.
Xcenda_2_3_Card-02

We’re here to help

Connect with our team today to learn more about how Cencora is helping to shape the future of healthcare.